Latest News

Federal Court Proceedings Demonstrate Risk To Compounding Pharmacies
MEDIA RELEASE 3rd August 2017 A recent Federal Court case highlights the very real risk and cost to Compounding Pharmacies who do not… Continue Reading →

FDA releases Industry Guidance for Low Sexual Interest, Desire and/or Arousal in Women
In late October 2016 the US FDA released draft guidance for Industry on Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment. … Continue Reading →

Flibanserin, the drug that gives women one extra sexually satisfying experience every two months
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months

The Testosterone and Exercise (TEX) Trial
Status: Study completed October 2018. Analysis of results underway. The University of Western Australia and Fiona Stanley Hospital are now recruiting for the TEX… Continue Reading →

Participants Required For Men’s Testosterone Study
Professor David J Handelsman (Andrology Dept, Concord Hospital, ANZAC Research Institute, Sydney) is looking to recruit 15 healthy male volunteers to participate in a… Continue Reading →

Current Guidelines For Prescribing Testosterone On The PBS
The Pharmaceutical Benefits Advisory Committee announced new prescribing criteria for testosterone effective from the 1st of April 2015. The main changes that were made are… Continue Reading →

New Testosterone Cream for Women Study
Monash Women’s Health Research Centre (Melbourne) is seeking women to participate in a new study to determine the optimum application of a 1% testosterone… Continue Reading →

The World Menopause Congress 2014
The 14th World Menopause Congress was held in Cancun Mexico from May 1-4, 2014. There were numerous sessions covering female sexual health in the… Continue Reading →